NEW YORK (GenomeWeb) – Vela Diagnostics announced today that its next-generation sequencing-based Sentosa SQ HIV genotyping assay is now CE-IVD marked for in vitro diagnostic usage.The company plans to use the assay to detect HIV-1 Group M genomic mutations in protease, reverse transcriptase, and integrase regions from plasma in patients with HIV.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.